These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 1597127

  • 21. Identical kinetics of human erythrocyte and muscle acetylcholinesterase with respect to carbamate pre-treatment, residual activity upon soman challenge and spontaneous reactivation after withdrawal of the inhibitors.
    Herkert NM, Eckert S, Eyer P, Bumm R, Weber G, Thiermann H, Worek F.
    Toxicology; 2008 Apr 18; 246(2-3):188-92. PubMed ID: 18304715
    [Abstract] [Full Text] [Related]

  • 22. Protection by pyridostigmine bromide of marmoset hemi-diaphragm acetylcholinesterase activity after soman exposure.
    Haigh JR, Adler M, Apland JP, Deshpande SS, Barham CB, Desmond P, Koplovitz I, Lenz DE, Gordon RK.
    Chem Biol Interact; 2010 Sep 06; 187(1-3):416-20. PubMed ID: 20144889
    [Abstract] [Full Text] [Related]

  • 23. A comparison of the decarbamoylation rates of physostigmine-inhibited plasma and red cell cholinesterases of man with other species.
    Wetherell JR, French MC.
    Biochem Pharmacol; 1991 Jul 15; 42(3):515-20. PubMed ID: 1907148
    [Abstract] [Full Text] [Related]

  • 24. The oximes HI-6 and MMB-4 fail to reactivate soman-inhibited human and guinea pig AChE: A kinetic in vitro study.
    Worek F, Thiermann H, Wille T.
    Toxicol Lett; 2018 Sep 01; 293():216-221. PubMed ID: 28993240
    [Abstract] [Full Text] [Related]

  • 25. Evaluation of the efficacy of two carbamates, physostigmine and pyridostigmine, when used in conjunction for protection against organophosphate exposure.
    Solana RP, Gennings C, Carter WH, Anderson D, Lennox WJ, Carchman RA, Harris LW.
    Fundam Appl Toxicol; 1990 Nov 01; 15(4):814-9. PubMed ID: 2086320
    [Abstract] [Full Text] [Related]

  • 26. Huperzine A as a pretreatment candidate drug against nerve agent toxicity.
    Grunwald J, Raveh L, Doctor BP, Ashani Y.
    Life Sci; 1994 Nov 01; 54(14):991-7. PubMed ID: 8139389
    [Abstract] [Full Text] [Related]

  • 27. Assessing the efficacy of azaprophen and physostigmine as a pretreatment for soman-induced incapacitation in guinea pigs by response-surface modeling.
    Gennings C, Carter WH, Harris LW, Carchman RA, Campbell ED, Boyle RM, Talbot BG, Solana RP.
    Fundam Appl Toxicol; 1990 Feb 01; 14(2):235-42. PubMed ID: 2318349
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Evaluation of antidotal effects of adamantyl derivative Tamorf in soman poisoning.
    Lucić Vrdoljak A, Radić B, Garaj-Vrhovac V, Kopjar N, Zlender V.
    J Appl Toxicol; 2006 Feb 01; 26(1):56-63. PubMed ID: 16167315
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Physostigmine (alone and together with adjunct) pretreatment against soman, sarin, tabun and VX intoxication.
    Harris LW, Talbot BG, Lennox WJ, Anderson DR, Solana RP.
    Drug Chem Toxicol; 1991 Feb 01; 14(3):265-81. PubMed ID: 1935706
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The effect of pyridostigmine pretreatment on oxime efficacy against intoxication by soman or VX in rats.
    Anderson DR, Harris LW, Woodard CL, Lennox WJ.
    Drug Chem Toxicol; 1992 Feb 01; 15(4):285-94. PubMed ID: 1459041
    [Abstract] [Full Text] [Related]

  • 38. Protection by a transdermal patch containing physostigmine and procyclidine of soman poisoning in dogs.
    Kim WS, Cho Y, Kim JC, Huang ZZ, Park SH, Choi EK, Shin S, Nam SY, Kang JK, Hwang SY, Kim YB.
    Eur J Pharmacol; 2005 Nov 21; 525(1-3):135-42. PubMed ID: 16256978
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.